Loading…

Two separate mechanisms for ligand-independent activation of the estrogen receptor

Transient transfection experiments in which three different estrogen response element-containing reporter genes were cotransfected into HeLa cells, together with constitutively expressed estrogen receptor (ER) constructs, demonstrate that activation of the transcription of the reporter genes by epid...

Full description

Saved in:
Bibliographic Details
Published in:Molecular endocrinology (Baltimore, Md.) Md.), 1997-06, Vol.11 (7), p.928-937
Main Authors: El-Tanani, M K, Green, C D
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c248t-df823d2e7f864a008ed273a939cbf2fb017cb1d318a83b51347e43ab4c713093
cites
container_end_page 937
container_issue 7
container_start_page 928
container_title Molecular endocrinology (Baltimore, Md.)
container_volume 11
creator El-Tanani, M K
Green, C D
description Transient transfection experiments in which three different estrogen response element-containing reporter genes were cotransfected into HeLa cells, together with constitutively expressed estrogen receptor (ER) constructs, demonstrate that activation of the transcription of the reporter genes by epidermal growth factor (EGF) and by cholera toxin with 3-isobutyl-1-methyl-xanthine, which elevate cellular cAMP, is dependent upon the presence of functional ER. Cotransfection of the reporter genes with truncated versions of the ER shows that the two non-ligand activators of ER require different regions of the receptor to produce their effects on transcription. EGF acts primarily by means of transactivation domain AF-1, whereas cAMP acts via transactivation domain AF-2 of the ER. A point mutation that removes a major site of inducible phosphorylation within the AF-1 domain of the ER abolishes the response to EGF, but the response to estradiol and cAMP is retained. Specific inhibition of cAMP-activated protein kinase (protein kinase A) prevents the response to elevated cAMP but does not affect EGF or estradiol responses. Overexpression of the protein kinase A catalytic subunit in HeLa cells results in an amplified response to estradiol, similar to that induced by cholera toxin with 3-isobutyl-1-methyl-xanthine. Comparable experiments performed using COS-1 cells produce similar results but also reveal cell type- and promoter-specific aspects of the activation mechanisms. Apparently, the ER may be activated by three different signal molecules, estradiol, EGF, and cAMP, each using a mechanism that is distinguishable from that of the others.
doi_str_mv 10.1210/me.11.7.928
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_79038322</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79038322</sourcerecordid><originalsourceid>FETCH-LOGICAL-c248t-df823d2e7f864a008ed273a939cbf2fb017cb1d318a83b51347e43ab4c713093</originalsourceid><addsrcrecordid>eNqFkD1PwzAURT2ASilMzEie2BL87LR-HlHFl1QJCXWPHOe5DUriYLsg_j0gurPcuxwdXV3GrkCUIEHcDlQClLo0Ek_YXCBigSjMGTtP6U0IqJYIMzYzoFEv5Zy9bj8DTzTZaDPxgdzejl0aEvch8r7b2bEturGliX5izNy63H3Y3IWRB8_znjilHMOORh7J0ZRDvGCn3vaJLo-9YNuH--36qdi8PD6v7zaFkxXmovUoVStJe1xVVgikVmpljTKu8dI3ArRroFWAFlWzBFVpqpRtKqdBCaMW7OZPO8XwfvhZUQ9dctT3dqRwSLU2QqGS8l8QVlIZgF_j9RE8NAO19RS7wcav-niW-gZYD2mj</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16239119</pqid></control><display><type>article</type><title>Two separate mechanisms for ligand-independent activation of the estrogen receptor</title><source>Oxford Journals Online</source><creator>El-Tanani, M K ; Green, C D</creator><creatorcontrib>El-Tanani, M K ; Green, C D</creatorcontrib><description>Transient transfection experiments in which three different estrogen response element-containing reporter genes were cotransfected into HeLa cells, together with constitutively expressed estrogen receptor (ER) constructs, demonstrate that activation of the transcription of the reporter genes by epidermal growth factor (EGF) and by cholera toxin with 3-isobutyl-1-methyl-xanthine, which elevate cellular cAMP, is dependent upon the presence of functional ER. Cotransfection of the reporter genes with truncated versions of the ER shows that the two non-ligand activators of ER require different regions of the receptor to produce their effects on transcription. EGF acts primarily by means of transactivation domain AF-1, whereas cAMP acts via transactivation domain AF-2 of the ER. A point mutation that removes a major site of inducible phosphorylation within the AF-1 domain of the ER abolishes the response to EGF, but the response to estradiol and cAMP is retained. Specific inhibition of cAMP-activated protein kinase (protein kinase A) prevents the response to elevated cAMP but does not affect EGF or estradiol responses. Overexpression of the protein kinase A catalytic subunit in HeLa cells results in an amplified response to estradiol, similar to that induced by cholera toxin with 3-isobutyl-1-methyl-xanthine. Comparable experiments performed using COS-1 cells produce similar results but also reveal cell type- and promoter-specific aspects of the activation mechanisms. Apparently, the ER may be activated by three different signal molecules, estradiol, EGF, and cAMP, each using a mechanism that is distinguishable from that of the others.</description><identifier>ISSN: 0888-8809</identifier><identifier>DOI: 10.1210/me.11.7.928</identifier><identifier>PMID: 9178752</identifier><language>eng</language><publisher>United States</publisher><subject>1-Methyl-3-isobutylxanthine - pharmacology ; Animals ; COS Cells ; Cyclic AMP - pharmacology ; Cyclic AMP-Dependent Protein Kinases - genetics ; Enzyme Inhibitors - pharmacology ; Epidermal Growth Factor - pharmacology ; Estradiol - pharmacology ; Gene Expression Regulation, Developmental - drug effects ; Gene Expression Regulation, Developmental - genetics ; Genes, Reporter - drug effects ; Genes, Reporter - genetics ; HeLa Cells ; Humans ; Isoquinolines - pharmacology ; Point Mutation - genetics ; Promoter Regions, Genetic - drug effects ; Promoter Regions, Genetic - genetics ; Receptors, Estrogen - drug effects ; Receptors, Estrogen - genetics ; Sulfonamides ; Transcriptional Activation - drug effects ; Transcriptional Activation - genetics ; Transfection - genetics</subject><ispartof>Molecular endocrinology (Baltimore, Md.), 1997-06, Vol.11 (7), p.928-937</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c248t-df823d2e7f864a008ed273a939cbf2fb017cb1d318a83b51347e43ab4c713093</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9178752$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>El-Tanani, M K</creatorcontrib><creatorcontrib>Green, C D</creatorcontrib><title>Two separate mechanisms for ligand-independent activation of the estrogen receptor</title><title>Molecular endocrinology (Baltimore, Md.)</title><addtitle>Mol Endocrinol</addtitle><description>Transient transfection experiments in which three different estrogen response element-containing reporter genes were cotransfected into HeLa cells, together with constitutively expressed estrogen receptor (ER) constructs, demonstrate that activation of the transcription of the reporter genes by epidermal growth factor (EGF) and by cholera toxin with 3-isobutyl-1-methyl-xanthine, which elevate cellular cAMP, is dependent upon the presence of functional ER. Cotransfection of the reporter genes with truncated versions of the ER shows that the two non-ligand activators of ER require different regions of the receptor to produce their effects on transcription. EGF acts primarily by means of transactivation domain AF-1, whereas cAMP acts via transactivation domain AF-2 of the ER. A point mutation that removes a major site of inducible phosphorylation within the AF-1 domain of the ER abolishes the response to EGF, but the response to estradiol and cAMP is retained. Specific inhibition of cAMP-activated protein kinase (protein kinase A) prevents the response to elevated cAMP but does not affect EGF or estradiol responses. Overexpression of the protein kinase A catalytic subunit in HeLa cells results in an amplified response to estradiol, similar to that induced by cholera toxin with 3-isobutyl-1-methyl-xanthine. Comparable experiments performed using COS-1 cells produce similar results but also reveal cell type- and promoter-specific aspects of the activation mechanisms. Apparently, the ER may be activated by three different signal molecules, estradiol, EGF, and cAMP, each using a mechanism that is distinguishable from that of the others.</description><subject>1-Methyl-3-isobutylxanthine - pharmacology</subject><subject>Animals</subject><subject>COS Cells</subject><subject>Cyclic AMP - pharmacology</subject><subject>Cyclic AMP-Dependent Protein Kinases - genetics</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Epidermal Growth Factor - pharmacology</subject><subject>Estradiol - pharmacology</subject><subject>Gene Expression Regulation, Developmental - drug effects</subject><subject>Gene Expression Regulation, Developmental - genetics</subject><subject>Genes, Reporter - drug effects</subject><subject>Genes, Reporter - genetics</subject><subject>HeLa Cells</subject><subject>Humans</subject><subject>Isoquinolines - pharmacology</subject><subject>Point Mutation - genetics</subject><subject>Promoter Regions, Genetic - drug effects</subject><subject>Promoter Regions, Genetic - genetics</subject><subject>Receptors, Estrogen - drug effects</subject><subject>Receptors, Estrogen - genetics</subject><subject>Sulfonamides</subject><subject>Transcriptional Activation - drug effects</subject><subject>Transcriptional Activation - genetics</subject><subject>Transfection - genetics</subject><issn>0888-8809</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNqFkD1PwzAURT2ASilMzEie2BL87LR-HlHFl1QJCXWPHOe5DUriYLsg_j0gurPcuxwdXV3GrkCUIEHcDlQClLo0Ek_YXCBigSjMGTtP6U0IqJYIMzYzoFEv5Zy9bj8DTzTZaDPxgdzejl0aEvch8r7b2bEturGliX5izNy63H3Y3IWRB8_znjilHMOORh7J0ZRDvGCn3vaJLo-9YNuH--36qdi8PD6v7zaFkxXmovUoVStJe1xVVgikVmpljTKu8dI3ArRroFWAFlWzBFVpqpRtKqdBCaMW7OZPO8XwfvhZUQ9dctT3dqRwSLU2QqGS8l8QVlIZgF_j9RE8NAO19RS7wcav-niW-gZYD2mj</recordid><startdate>199706</startdate><enddate>199706</enddate><creator>El-Tanani, M K</creator><creator>Green, C D</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7TM</scope><scope>7X8</scope></search><sort><creationdate>199706</creationdate><title>Two separate mechanisms for ligand-independent activation of the estrogen receptor</title><author>El-Tanani, M K ; Green, C D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c248t-df823d2e7f864a008ed273a939cbf2fb017cb1d318a83b51347e43ab4c713093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>1-Methyl-3-isobutylxanthine - pharmacology</topic><topic>Animals</topic><topic>COS Cells</topic><topic>Cyclic AMP - pharmacology</topic><topic>Cyclic AMP-Dependent Protein Kinases - genetics</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Epidermal Growth Factor - pharmacology</topic><topic>Estradiol - pharmacology</topic><topic>Gene Expression Regulation, Developmental - drug effects</topic><topic>Gene Expression Regulation, Developmental - genetics</topic><topic>Genes, Reporter - drug effects</topic><topic>Genes, Reporter - genetics</topic><topic>HeLa Cells</topic><topic>Humans</topic><topic>Isoquinolines - pharmacology</topic><topic>Point Mutation - genetics</topic><topic>Promoter Regions, Genetic - drug effects</topic><topic>Promoter Regions, Genetic - genetics</topic><topic>Receptors, Estrogen - drug effects</topic><topic>Receptors, Estrogen - genetics</topic><topic>Sulfonamides</topic><topic>Transcriptional Activation - drug effects</topic><topic>Transcriptional Activation - genetics</topic><topic>Transfection - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>El-Tanani, M K</creatorcontrib><creatorcontrib>Green, C D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Nucleic Acids Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Molecular endocrinology (Baltimore, Md.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>El-Tanani, M K</au><au>Green, C D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Two separate mechanisms for ligand-independent activation of the estrogen receptor</atitle><jtitle>Molecular endocrinology (Baltimore, Md.)</jtitle><addtitle>Mol Endocrinol</addtitle><date>1997-06</date><risdate>1997</risdate><volume>11</volume><issue>7</issue><spage>928</spage><epage>937</epage><pages>928-937</pages><issn>0888-8809</issn><abstract>Transient transfection experiments in which three different estrogen response element-containing reporter genes were cotransfected into HeLa cells, together with constitutively expressed estrogen receptor (ER) constructs, demonstrate that activation of the transcription of the reporter genes by epidermal growth factor (EGF) and by cholera toxin with 3-isobutyl-1-methyl-xanthine, which elevate cellular cAMP, is dependent upon the presence of functional ER. Cotransfection of the reporter genes with truncated versions of the ER shows that the two non-ligand activators of ER require different regions of the receptor to produce their effects on transcription. EGF acts primarily by means of transactivation domain AF-1, whereas cAMP acts via transactivation domain AF-2 of the ER. A point mutation that removes a major site of inducible phosphorylation within the AF-1 domain of the ER abolishes the response to EGF, but the response to estradiol and cAMP is retained. Specific inhibition of cAMP-activated protein kinase (protein kinase A) prevents the response to elevated cAMP but does not affect EGF or estradiol responses. Overexpression of the protein kinase A catalytic subunit in HeLa cells results in an amplified response to estradiol, similar to that induced by cholera toxin with 3-isobutyl-1-methyl-xanthine. Comparable experiments performed using COS-1 cells produce similar results but also reveal cell type- and promoter-specific aspects of the activation mechanisms. Apparently, the ER may be activated by three different signal molecules, estradiol, EGF, and cAMP, each using a mechanism that is distinguishable from that of the others.</abstract><cop>United States</cop><pmid>9178752</pmid><doi>10.1210/me.11.7.928</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0888-8809
ispartof Molecular endocrinology (Baltimore, Md.), 1997-06, Vol.11 (7), p.928-937
issn 0888-8809
language eng
recordid cdi_proquest_miscellaneous_79038322
source Oxford Journals Online
subjects 1-Methyl-3-isobutylxanthine - pharmacology
Animals
COS Cells
Cyclic AMP - pharmacology
Cyclic AMP-Dependent Protein Kinases - genetics
Enzyme Inhibitors - pharmacology
Epidermal Growth Factor - pharmacology
Estradiol - pharmacology
Gene Expression Regulation, Developmental - drug effects
Gene Expression Regulation, Developmental - genetics
Genes, Reporter - drug effects
Genes, Reporter - genetics
HeLa Cells
Humans
Isoquinolines - pharmacology
Point Mutation - genetics
Promoter Regions, Genetic - drug effects
Promoter Regions, Genetic - genetics
Receptors, Estrogen - drug effects
Receptors, Estrogen - genetics
Sulfonamides
Transcriptional Activation - drug effects
Transcriptional Activation - genetics
Transfection - genetics
title Two separate mechanisms for ligand-independent activation of the estrogen receptor
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T13%3A24%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Two%20separate%20mechanisms%20for%20ligand-independent%20activation%20of%20the%20estrogen%20receptor&rft.jtitle=Molecular%20endocrinology%20(Baltimore,%20Md.)&rft.au=El-Tanani,%20M%20K&rft.date=1997-06&rft.volume=11&rft.issue=7&rft.spage=928&rft.epage=937&rft.pages=928-937&rft.issn=0888-8809&rft_id=info:doi/10.1210/me.11.7.928&rft_dat=%3Cproquest_pubme%3E79038322%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c248t-df823d2e7f864a008ed273a939cbf2fb017cb1d318a83b51347e43ab4c713093%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16239119&rft_id=info:pmid/9178752&rfr_iscdi=true